Angela West joined the Center for Psychedelic Medicine in November 2021 as a Research Coordinator. She has an extensive work history, having provided mental health services in homes, schools, residential facilities, and psychiatric hospitals; she served both children and adults with varying developmental, behavioral, and mental health challenges (Autism, trauma, traumatic brain injuries, substance use disorders, schizophrenia, etc.).
Angela received her BA in Psychology at the University of Maine at Farmington and is a recent graduate from John Jay College of Criminal Justice with a MA in Forensic Psychology. She was involved in a clinical neuropsychology research lab and her thesis explored the relationship between neurocognitive disinhibition, substance use, and crime. Angela values the expansion of treatment options that psychedelic medicine provides, and she plans on becoming a psychedelic-assisted psychotherapist with an interest in accessibility and equity, particularly with serving individuals with substance use disorders within the criminal justice system.
Angela is working with Dr. Stephen Ross on the CBD for Opioid Sparing in Chronic Radicular Pain study, and the upcoming LSD study for cancer patients with existential and psychological distress. She is the primary point of contact for the study team and participants. She is involved in recruiting, scheduling, and screening participants, assisting with their study visits, managing finances and day-to-day study activities, leading weekly team meetings, and maintaining regulatory standards.